Thermo Fisher Scientific Inc. closed $67.09 below its 52-week high ($627.88), which the company achieved on September 10th.
Thermo Fisher Scientific and Novo Nordisk Foundation Cellerator have partnered to shape the future of cell manufacturing at a newfound innovation hub ...
Op donderdag heeft Baird het koersdoel voor Thermo Fisher Scientific (NYSE:TMO) verlaagd naar €622 van het eerdere €632, terwijl het bedrijf zijn Outperform-rating voor de aandelen handhaafde. De aanp ...
Kunstmatige intelligentie (AI) is een van de populairste beleggingsthema's van 2024. AI bestaat in bepaalde vorm al ...
On Wednesday, Thermo Fisher Scientific Inc. (NYSE: TMO) posted third-quarter revenue of $10.59 billion, almost flat year over ...
Thermo Fisher Scientific's third-quarter profit declined and revenue missed estimates as its two biggest divisions struggled.
Thermo Fisher Scientific Inc. closed $81.56 short of its 52-week high ($627.88), which the company achieved on September 10th ...
Thermo Fisher Scientific (NYSE:TMO – Get Free Report) had its price objective decreased by investment analysts at Barclays ...
Key Insights Using the 2 Stage Free Cash Flow to Equity, Thermo Fisher Scientific fair value estimate is US$800 ...
Thermo Fisher Scientific Inc.'s Q3 results demonstrated some end-market stability, particularly in the life science market.
Mount Yale Investment Advisors LLC lessened its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 23.0% ...